ClinVar Genomic variation as it relates to human health
NM_004448.4(ERBB2):c.3611C>G (p.Ala1204Gly)
The aggregate germline classification for this variant, typically for a monogenic or Mendelian disorder as in the ACMG/AMP guidelines, or for response to a drug. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the aggregate classification.
Stars represent the aggregate review status, or the level of review supporting the aggregate germline classification for this VCV record. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. The number of submissions which contribute to this review status is shown in parentheses.
No data submitted for somatic clinical impact
No data submitted for oncogenicity
Variant Details
- Identifiers
-
NM_004448.4(ERBB2):c.3611C>G (p.Ala1204Gly)
Variation ID: 1428662 Accession: VCV001428662.6
- Type and length
-
single nucleotide variant, 1 bp
- Location
-
Cytogenetic: 17q12 17: 39727887 (GRCh38) [ NCBI UCSC ] 17: 37884140 (GRCh37) [ NCBI UCSC ]
- Timeline in ClinVar
-
First in ClinVar Help The date this variant first appeared in ClinVar with each type of classification.
Last submission Help The date of the most recent submission for each type of classification for this variant.
Last evaluated Help The most recent date that a submitter evaluated this variant for each type of classification.
Germline Mar 28, 2022 Feb 20, 2024 Mar 27, 2021 - HGVS
-
Nucleotide Protein Molecular
consequenceNM_004448.4:c.3611C>G MANE Select Help Transcripts from the Matched Annotation from the NCBI and EMBL-EBI (MANE) collaboration.
NP_004439.2:p.Ala1204Gly missense NM_001005862.3:c.3521C>G NP_001005862.1:p.Ala1174Gly missense NM_001289936.2:c.3566C>G NP_001276865.1:p.Ala1189Gly missense NM_001289937.2:c.*190C>G 3 prime UTR NM_001382782.1:c.3521C>G NP_001369711.1:p.Ala1174Gly missense NM_001382783.1:c.3521C>G NP_001369712.1:p.Ala1174Gly missense NM_001382784.1:c.3728C>G NP_001369713.1:p.Ala1243Gly missense NM_001382785.1:c.3713C>G NP_001369714.1:p.Ala1238Gly missense NM_001382786.1:c.3692C>G NP_001369715.1:p.Ala1231Gly missense NM_001382787.1:c.3686C>G NP_001369716.1:p.Ala1229Gly missense NM_001382788.1:c.3641C>G NP_001369717.1:p.Ala1214Gly missense NM_001382789.1:c.3632C>G NP_001369718.1:p.Ala1211Gly missense NM_001382790.1:c.3608C>G NP_001369719.1:p.Ala1203Gly missense NM_001382791.1:c.3602C>G NP_001369720.1:p.Ala1201Gly missense NM_001382792.1:c.3575C>G NP_001369721.1:p.Ala1192Gly missense NM_001382793.1:c.3569C>G NP_001369722.1:p.Ala1190Gly missense NM_001382794.1:c.3569C>G NP_001369723.1:p.Ala1190Gly missense NM_001382795.1:c.3563C>G NP_001369724.1:p.Ala1188Gly missense NM_001382796.1:c.3524C>G NP_001369725.1:p.Ala1175Gly missense NM_001382797.1:c.3512C>G NP_001369726.1:p.Ala1171Gly missense NM_001382798.1:c.3455C>G NP_001369727.1:p.Ala1152Gly missense NM_001382799.1:c.3431C>G NP_001369728.1:p.Ala1144Gly missense NM_001382800.1:c.3425C>G NP_001369729.1:p.Ala1142Gly missense NM_001382801.1:c.3407C>G NP_001369730.1:p.Ala1136Gly missense NM_001382802.1:c.3353C>G NP_001369731.1:p.Ala1118Gly missense NM_001382803.1:c.*190C>G 3 prime UTR NM_001382804.1:c.2783C>G NP_001369733.1:p.Ala928Gly missense NM_001382805.1:c.2660C>G NP_001369734.1:p.Ala887Gly missense NM_001382806.1:c.2573C>G NP_001369735.1:p.Ala858Gly missense NR_110535.2:n.3849C>G non-coding transcript variant NC_000017.11:g.39727887C>G NC_000017.10:g.37884140C>G NG_007503.1:g.44748C>G LRG_724:g.44748C>G - Protein change
- A1136G, A1144G, A1171G, A1201G, A1188G, A1189G, A1204G, A1229G, A1231G, A1238G, A1243G, A1174G, A1175G, A1190G, A1192G, A858G, A887G, A928G, A1118G, A1142G, A1152G, A1203G, A1211G, A1214G
- Other names
- -
- Canonical SPDI
- NC_000017.11:39727886:C:G
-
Functional
consequence HelpThe effect of the variant on RNA or protein function, based on experimental evidence from submitters.
- -
-
Global minor allele
frequency (GMAF) HelpThe global minor allele frequency calculated by the 1000 Genomes Project. The minor allele at this location is indicated in parentheses and may be different from the allele represented by this VCV record.
- -
-
Allele frequency
Help
The frequency of the allele represented by this VCV record.
-
The Genome Aggregation Database (gnomAD) 0.00001
Trans-Omics for Precision Medicine (TOPMed) 0.00001
NHLBI Exome Sequencing Project (ESP) Exome Variant Server 0.00008
- Links
Genes
Gene | OMIM | ClinGen Gene Dosage Sensitivity Curation |
Variation Viewer
Help
Links to Variation Viewer, a genome browser to view variation data from NCBI databases. |
Related variants | ||
---|---|---|---|---|---|---|
HI score
Help
The haploinsufficiency score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
TS score
Help
The triplosensitivity score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
Within gene
Help
The number of variants in ClinVar that are contained within this gene, with a link to view the list of variants. |
All
Help
The number of variants in ClinVar for this gene, including smaller variants within the gene and larger CNVs that overlap or fully contain the gene. |
|||
ERBB2 | - | - |
GRCh38 GRCh37 |
679 | 694 |
Conditions - Germline
Condition
Help
The condition for this variant-condition (RCV) record in ClinVar. |
Classification
Help
The aggregate germline classification for this variant-condition (RCV) record in ClinVar. The number of submissions that contribute to this aggregate classification is shown in parentheses. (# of submissions) |
Review status
Help
The aggregate review status for this variant-condition (RCV) record in ClinVar. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. |
Last evaluated
Help
The most recent date that a submitter evaluated this variant for the condition. |
Variation/condition record
Help
The RCV accession number, with most recent version number, for the variant-condition record, with a link to the RCV web page. |
---|---|---|---|---|
Uncertain significance (1) |
criteria provided, single submitter
|
Mar 27, 2021 | RCV001948329.6 |
Submissions - Germline
Classification
Help
The submitted germline classification for each SCV record. (Last evaluated) |
Review status
Help
Stars represent the review status, or the level of review supporting the submitted (SCV) record. This value is calculated by NCBI based on data from the submitter. Read our rules for calculating the review status. This column also includes a link to the submitter’s assertion criteria if provided, and the collection method. (Assertion criteria) |
Condition
Help
The condition for the classification, provided by the submitter for this submitted (SCV) record. This column also includes the affected status and allele origin of individuals observed with this variant. |
Submitter
Help
The submitting organization for this submitted (SCV) record. This column also includes the SCV accession and version number, the date this SCV first appeared in ClinVar, and the date that this SCV was last updated in ClinVar. |
More information
Help
This column includes more information supporting the classification, including citations, the comment on classification, and detailed evidence provided as observations of the variant by the submitter. |
|
---|---|---|---|---|---|
Uncertain significance
(Mar 27, 2021)
|
criteria provided, single submitter
Method: clinical testing
|
not provided
Affected status: unknown
Allele origin:
germline
|
Labcorp Genetics (formerly Invitae), Labcorp
Accession: SCV002206648.3
First in ClinVar: Mar 28, 2022 Last updated: Feb 20, 2024 |
Comment:
This variant is not present in population databases (ExAC no frequency). In summary, the available evidence is currently insufficient to determine the role of this … (more)
This variant is not present in population databases (ExAC no frequency). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated, but these predictions have not been confirmed by published functional studies and their clinical significance is uncertain. This variant has not been reported in the literature in individuals with ERBB2-related conditions. This sequence change replaces alanine with glycine at codon 1204 of the ERBB2 protein (p.Ala1204Gly). The alanine residue is weakly conserved and there is a small physicochemical difference between alanine and glycine. (less)
|
Germline Functional Evidence
There is no functional evidence in ClinVar for this variation. If you have generated functional data for this variation, please consider submitting that data to ClinVar. |
Citations for germline classification of this variant
HelpThere are no citations for germline classification of this variant in ClinVar. If you know of citations for this variation, please consider submitting that information to ClinVar. |
Text-mined citations for rs373605104 ...
HelpRecord last updated Sep 29, 2024
This date represents the last time this VCV record was updated. The update may be due to an update to one of the included submitted records (SCVs), or due to an update that ClinVar made to the variant such as adding HGVS expressions or a rs number. So this date may be different from the date of the “most recent submission” reported at the top of this page.